Paulson support for vrx...

Discussion in 'Valeant Pharmaceuticals' started by Anonymous, Nov 15, 2014 at 5:48 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    The $24 billion New York firm, which bets on mergers, also pared down its stake in Allergan Inc.AGN +1.24% to 5,377,200 shares, valued at $958.2 million as of Sept. 30, and increased its position in Valeant Pharmaceuticals International Inc.'sVRX.T +0.88% to $68.3 million, according to the filing.
     

  2. Anonymous

    Anonymous Guest

    Smart. AGN has had a nice run but now there is more upside potential with VRX. ValueAct has been increasing it's VRX stake as well.
     
  3. Anonymous

    Anonymous Guest

    Is Paulson still owning vrx?
     
  4. Anonymous

    Anonymous Guest

    If he owned VXR, it was a small position. Paulson was big in Allergan and Salix which is why he was mentioned here. The buyouts made him a lot of money.

    He's also in Mylan, Actavis and AbbVie. Maybe these are future take over targets.
     
  5. Anonymous

    Anonymous Guest

    Is Paulson still supporting VRX stock?
     
  6. Anonymous

    Anonymous Guest

    He's been pretty quiet lately